About BioProtect
We are spacing innovators powering treatment forward.
Our Mission
BioProtect’s mission is to empower healthcare providers with spacing innovations that elevate prostate cancer care and enhance patient quality of life.
Our Vision
BioProtect envisions a world with more advancements in cancer care, more room for patients to thrive, and more space for life after treatment.
Meet the BioProtect Team
BioProtect By the Numbers
Following ISO 13485:2016 certification, the BioProtect Balloon Spacer was cleared for use in the United States in 2023 and commercially launched later that year.
Over 11,000 BioProtect Balloon Spacer procedures have been performed worldwide.
BioProtect Balloon Spacer has appeared in 26 peer-reviewed publications.
BioProtect employs more than 120 team members worldwide.
Investor Information
For corporate information and investor contacts, please contact the BioProtect team.
BioProtect Careers
Explore our open positions.